Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

GENEREX BIOTECHNOLOGY CORP (GNBT)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsApr-30-21Jan-31-21Oct-31-20Jul-31-20Apr-30-20Jan-31-20Oct-31-19Jul-31-19
   10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K
Net income  -33.3-33.3-33.3-33.3-9.3-9.3-9.3-9.3
Depreciation and amortization   [+]1.00.90.90.80.50.50.60.4
Asset impairment charges         0.3
Stock-based compensation  2.62.62.52.13.14.23.73.0
Deferred taxes  10.78.75.7-67.3   6.6
Change in working capital   [+]22.522.017.510.17.910.111.911.0
Other operating activities  -5.9-4.71.081.5-15.9-22.4-24.8-21.6
Cash from operations  -2.4-3.8-5.6-6.1-7.0-10.2-11.1-9.6
   
Capital expenditures   [+]0.00.00.00.00.0-0.3-0.3-0.3
Other cash from investing        1.3 
Cash from investing  0.00.00.00.00.10.71.32.3
   
Issuance of common stock, net  3.73.02.3  0.1  
Other cash from financing  -0.11.13.65.75.87.37.96.5
Cash from financing  3.64.25.95.85.97.47.96.5
   
Free cash flow  -2.4-3.8-5.6-6.1-7.0-10.5-11.3-9.9
        Per share (diluted)  ($0.02)($0.04)($0.07)($0.09)($0.10)($0.15)($0.16)($0.15)
   
Cash paid for interest    0.1   0.0 

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy